ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

8,164Medicare Part D Prescriptions Filled, Including Refills
$863K Total Retail Price of All Prescriptions
677 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
ZOLPIDEM TARTRATE 588 328
HYDROCODONE-ACETAMINOPHEN 331 188 S3
OMEPRAZOLE 298 156
AZITHROMYCIN 276 173
SPIRIVA 237 168
FUROSEMIDE 231 121
ADVAIR DISKUS 214 132
POTASSIUM CHLORIDE 207 103
SINGULAIR 200 126
PROAIR HFA 181 117
METHYLPREDNISOLONE 177 107
ROPINIROLE HCL 168 106
TRAMADOL HCL 162 65
CITALOPRAM HBR 158 112
MONTELUKAST SODIUM 151 97
VENTOLIN HFA 137 55
SIMVASTATIN 126 82
GABAPENTIN 126 49
SYMBICORT 112 85
METFORMIN HCL 107 71
PREDNISONE 105 65
LEVOFLOXACIN 103 75
NEXIUM 99 65
LEVOTHYROXINE SODIUM 87 61
ATENOLOL 84 78
PANTOPRAZOLE SODIUM 83 47
PRAVASTATIN SODIUM 76 54
CYCLOBENZAPRINE HCL 75 31 R
MELOXICAM 73 48
LOSARTAN POTASSIUM 72 67
LISINOPRIL 70 47
PRAMIPEXOLE DIHYDROCHLORIDE 68 45
SERTRALINE HCL 60 35
TAMSULOSIN HCL 58 31
CYMBALTA 56 39
COMBIVENT 56 25
AMLODIPINE BESYLATE 55 51
BISOPROLOL FUMARATE 54 12
SPIRONOLACTONE 54 30
PROMETHAZINE HCL 51 11 R
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.